2023-12-04
Financial Times
5 related
AstraZeneca signs a deal worth up to $247M with US-based Absci to harness its AI tech for large-scale protein analysis and design an antibody to fight cancer
2023-12-03
Financial Times
1 related
AstraZeneca signs a deal worth up to $247M with US-based Absci to harness its AI tech for large-scale protein analysis and design an antibody to fight cancer
Deal with Absci is the latest between big pharma and tech companies to build new disease treatments
Loading articles...